// App-Quantinova.ai

AB0221 (2021) : CURRENT IMPLEMENTATION OF TREAT-TO-TARGET APPROACH IN RHEUMATOID ARTHRITIS TREATMENT: THE PERSPECTIVE OF CHINESE RHEUMATOLOGISTS

Researchers

Presenter

  • J. L. Zhao

Principal Investigators

  • X. Liu

  • L. Zhan

  • H. Tang

  • J. Li

  • M. Liu

  • E. Holdsworth

  • Y. Zhao

Medical Centers

  • Peking Union Medical College Hospital, Department of Gastroenterology, Beijing, China

  • Eli Lilly and Company, Shanghai, China

  • Adelphi Real World, Rheumatology, Manchester, United Kingdom

Locations

  • China

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cross-Sectional

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved